Advanced age and the clinical outcomes of transcatheter aortic valve implantation

Journal of Geriatric Cardiology

Volumn 11, Issue 2, 2014, Pages 163-170

  Alsara, Osama ^a   Alsarah, Ahmad ^a   Laird Fick, Heather ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Aortic stenosis; Geriatric; Surgical aortic valve replacement; Transcatheter aortic valve implantation

Indexed keywords

AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; BLOOD VESSEL INJURY; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; HUMAN; MORBIDITY; OUTCOME ASSESSMENT; REVIEW; SURGICAL AORTIC VALVE REPLACEMENT; SURGICAL RISK; TRANSCATHETER AORTIC VALVE IMPLANTATION;

EID: 84904510432     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1671-5411.2014.02.004     Document Type: Review

References (44)

1. Varadarajan P, Kapoor N, Bansal RC, et al. Survival in elderly patients with severe aortic stenosis is dramatically improved by aortic valve replacement: results from a cohort of 277 patients aged > or =80 years. Eur J Cardiothorac Surg 2006; 30: 722-727. (Pubitemid 44574533)
2. Huber CH, Goeber V, Berdat P, et al. Benefits of cardiac surgery in octogenarians - a postoperative quality of life assessment. Eur J Cardiothorac Surg 2007; 31: 1099-1105. (Pubitemid 46719955)
3. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005; 26: 2714-2720. (Pubitemid 41746694)
4. Sawaya F, Stewart J, Babaliaros V. Aortic stenosis: who should undergo surgery, transcatheter valve replacement? Cleve Clin J Med 2012; 79: 487-497.
5. Assmann A, Minol JP, Mehdiani A, et al. Cardiac surgery in nonagenarians: not only feasible, but also reasonable? Interact CardiovascThorac Surg 2013; 17: 340-343.
6. Kvidal P, Bergström R, Hörte LG, et al. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 2000; 35: 747-756. (Pubitemid 30167033)
7. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Euro-Intervention 2008; 4: 193-199.
8. O'Sullivan CJ, Stortecky S, Buellesfeld L, et al. Preinterventional screening of the TAVI patient: how to choose the suitable patient and the best procedure. Clin Res Cardiol 2014; 103: 259-274.
9. Bauer F, Eltchaninoff H, Tron C, et al. Acute improvement in global and regional left ventricular systolic function after percutaneous heart valve implantation in patients with symptomatic aortic stenosis. Circulation 2004; 110: 1473-1476. (Pubitemid 39238026)
10. Clavel MA, Webb JG, Pibarot P, et al. Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J Am Coll Cardiol 2009; 53: 1883-1891.
11. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116: 755-763. (Pubitemid 47255993)
12. Bekeredjian R, Krumsdorf U, Chorianopoulos E, et al. Usefulness of percutaneous aortic valve implantation to improve quality of life in patients >80 years of age. Am J Cardiol 2010; 15; 106: 1777-1781.
13. Ussia GP, Barbanti M, Cammalleri V, et al. Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis. EuroIntervention 2011; 7: 573-579.
14. Schoenenberger AW, Stortecky S, Neumann S, et al. Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (TAVI). Eur Heart J 2013; 34: 684-692.
15. Moat N, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis. The UK TAVI (United Kingdom Transcatheter Aortic Valve Implantation) registry. J Am Coll Cardiol 2011; 58: 2130-2138.
16. Blackman DJ, Baxter PD, Gale CP, et al. Do outcomes from transcatheter aortic valve implantation vary according to access route and valve type? The UK TAVI Registry. J Interv Cardiol 2014; 27: 86-95.
17. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-2198.
18. Zierer A, Wimmer-Greinecker G, Martens S, et al. Is transapical aortic valve implantation really less invasive than minimally invasive aortic valve replacement? J Thorac Cardiovasc Surg 2009; 138: 1067-1072.
19. De Carlo M, Giannini C, Ettori F, et al. Impact of treatment choice on the outcome of patients proposed for transcatheter aortic valve implantation. EuroIntervention 2010; 6: 568-574.
20. Kodali SK, Williams MR, Smith CR, et al PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 3; 366: 1686-1695.
21. Conradi L, Seiffert M, Treede H, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement: a propensity score analysis in patients at high surgical risk. J Thorac Cardiovasc Surg 2012; 143: 64-71.
22. Nielsen HH, Klaaborg KE, Nissen H, et al. A prospective, randomised trial of transapicaltranscatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial. EuroIntervention 2012; 8: 383-389.
23. Im E, Hong MK, Ko YG, et al. Comparison of early clinical outcomes following transcatheter aortic valve implantation versus surgical aortic valve replacement versus optimal medical therapy in patients older than 80 years with symptomatic severe aortic stenosis. Yonsei Med J 2013; 54: 596-602.
24. Silberman S, Abu Akr F, Bitran D, et al. Comparison between transcatheter and surgical aortic valve replacement: a single-center experience. J Heart Valve Dis 2013; 22: 448-454.
25. Piazza N, Kalesan B, van Mieghem N, et al. A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients. JACC Cardiovasc Interv 2013; 6: 443-451.
26. D'Errigo P, Barbanti M, Ranucci M, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: results from an intermediate risk propensity-matched population of the Italian OBSERVANT study. Int J Cardiol 2013; 67: 945-952.
27. Holzhey DM, Shi W, Rastan A, et al. Transapical versus conventional aortic valve replacement - a propensity-matched comparison. Heart Surg Forum 2012; 15: E4-E8.
28. Jabs A, Kilic T, Schnelle N, et al. Transcatheter aortic valve implantation and four-year follow up in a 99-year-old patient. J Heart Valve Dis 2013; 22: 261-264.
29. Verouhis D, Yamasaki K, Ivert T, et al. Transcatheter aortic valve implantation is feasible and safe in nonagenarians. J Am Geriatr Soc 2014; 62: 189-190.
30. Buellesfeld L, Gerckens U, Erbel R, et al. Age-stratified baseline and outcome characteristics of patients undergoing transcatheter aortic valve implantation: results from the German multicenter registry. J Invasive Cardiol 2012; 24: 531-536.
31. Havakuk O, Finkelstein A, Steinvil A, et al. Comparison of outcomes in patients ≤ 85 versus > 85 years of age undergoing transcatheter aortic-valve implantation. Am J Cardiol 2014; 113: 138-141.
32. Yamamoto M, Meguro K, Mouillet G, et al. Comparison of effectiveness and safety of transcatheter aortic valve implantation in patients aged ≥ 90 years versus < 90 years. Am J Cardiol 2012; 110: 1156-1163.
33. Go AS, Mozaffarian D, Roger VL, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2014 update: a report from the American Heart Association. Circulation 2014; 129: e28-e292.
34. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic bioprosthesis European outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010; 122: 62-69.
35. Poliacikova P, Cockburn J, de Belder A, et al. Antiplatelet and antithrombotic treatment after transcatheter aortic valve implantation - comparison of regimes. J Invasive Cardiol 2013; 25: 544-548.
36. Durand E, Blanchard D, Chassaing S, et al. Comparison of two antiplatelet therapy strategies in patients undergoing transcatheter aortic valve implantation. Am J Cardiol 2014; 113: 355-360.
37. Czerwińska-Jelonkiewicz K, Witkowski A, Da̧browski M, et al. Antithrombotic therapy - predictor of early and long-term bleeding complications after transcatheter aortic valve implantation. Arch Med Sci 2013; 9: 1062-1070.
38. Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA 2014; 311: 1503-1514.
39. Bagur R, Webb JG, Nietlispach F, et al. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J 2010; 31: 865-874.
40. Goebel N, Baumbach H, Ahad S, et al. Transcatheter aortic valve replacement: does kidney function affect outcome? Ann Thorac Surg 2013; 96: 507-512.
41. Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high risk patients. N Engl J Med 2012; 366: 1705-1715.
42. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011; 123: 299-308.
43. Colli A, Gallo M, Bernabeu E, et al. Aortic valve calcium scoring is a predictor of paravalvular aortic regurgitation after transcatheter aortic valve implantation. Ann Cardiothorac Surg 2012; 1: 156-159.
44. Khawaja MZ, Haworth P, Ghuran A, et al. Transcatheter aortic valve implantation for stenosed and regurgitant aortic valve bioprostheses CoreValve for failed bioprosthetic aortic valve replacements. J Am Coll Cardiol 2010; 55: 97-101.